| Type | Botanical Herb |
| Active Cmpd | Apigenin, Bisabolol, Chamazulene |
| Source | Matricaria chamomilla (German), Chamaemelum nobile (Roman) |
| Dose Range | 220 mg – 1,500 mg standardized extract |
| Half-life | ~1.5 – 2 hours (Apigenin) |
| Main Benefit | Anxiolysis, sleep quality, and glycemic control |
| Absorption | Low-to-moderate oral bioavailability (Apigenin) |
Chamomile is one of the most widely utilized botanical therapies globally, valued for its sedative, spasmolytic, and anti-inflammatory properties. Recent systematic clinical reviews demonstrate that high-dose, standardized oral chamomile extracts exert robust therapeutic benefit for mild-to-moderate Generalized Anxiety Disorder (GAD) and significantly improve sleep quality across clinical and aging populations.
¶ At a glance
¶ Aliases
- Also known as: German Chamomile, Roman Chamomile, Babuna, Camomile
- Chemical / botanical name: Matricaria chamomilla (syn. Matricaria recutita, German Chamomile), Chamaemelum nobile (syn. Anthemis nobilis, Roman Chamomile)
- Category: Botanical terpene and flavonoid source
¶ Key points (high-level summary)
- Anxiety & Sleep Support: In randomized clinical trials, standardized oral chamomile extract significantly reduces Hamilton Anxiety Rating Scale (HAM-A) scores in mild-to-moderate GAD and improves subjective sleep quality metrics in elderly and postpartum cohorts [1][2][3].
- Glycemic & Metabolic Benefits: Quantitative meta-analyses indicate chamomile consumption modestly reduces fasting blood glucose, HbA1c, and lipid profiles in patients with type 2 diabetes mellitus [4][5].
- Low Oral Bioavailability: Its primary active flavonoid, apigenin, has relatively low oral bioavailability and rapid clearance, requiring concentrated standardized extracts rather than simple weak teas to achieve therapeutic plasma levels for chronic anxiety [6].
- Asteraceae Sensitivity: While designated as Generally Recognized as Safe (GRAS) by regulatory authorities, individuals with hypersensitivity to Asteraceae family plants (ragweed, daisies) are at risk of rare allergic reactions [7].
¶ What people use it for
- Main goals: Sleep quality enhancement, anxiety management, chronic inflammation reduction, musculoskeletal pain relief, oral mucositis prevention during chemotherapy, and glycemic control.
- Evidence quality (overall): Moderate (supported by multiple high-quality systematic reviews and meta-analyses of clinical trials).
¶ What is Chamomile?
German Chamomile (Matricaria chamomilla) is an annual plant in the Asteraceae family native to Europe and Western Asia, representing the species most thoroughly validated in modern clinical research. Roman Chamomile (Chamaemelum nobile) is a perennial species with distinct morphology but overlapping phytochemistry.
- Definition: Chamomile is a daisy-like botanical herb containing a rich array of bioactive secondary metabolites, including volatile sesquiterpenes (alpha-bisabolol, chamazulene) and hydrophilic flavonoids (apigenin, luteolin, quercetin) [6:1].
- Natural sources: Flowers of the Matricaria chamomilla and Chamaemelum nobile plants.
- Traditional / historical use: Historically used in ancient Egyptian, Greek, and Roman medicine as an infusion for insomnia, gastrointestinal distress, fever, and wound healing [6:2].
- Current regulatory status: Commonly marketed as a dietary supplement or herbal tea globally. It holds Generally Recognized as Safe (GRAS) status under United States Food and Drug Administration (FDA) regulations and is included in the European Pharmacopoeia as a registered herbal remedy.
- Key pharmacological property in one line: A GABAergic sedative, anti-inflammatory, and spasmolytic botanical extract.
¶ What are Chamomile’s main benefits?
Clinical research has progressed beyond traditional applications, establishing distinct therapeutic targets for chamomile:
- Anxiety Management: Oral chamomile extract significantly reduces generalized anxiety symptoms. In clinical meta-analyses, standardized extracts ranging from 220 mg to 1,500 mg daily demonstrated progressive, cumulative efficacy over 2 to 8 weeks, comparable to standard first-line low-dose pharmacotherapy without daytime cognitive impairment [1:1][2:1].
- Sleep Quality Improvement: Clinical trials in elderly populations and postpartum women demonstrate significant improvement in subjective sleep quality scores and reduced sleep onset latency. However, it does not show statistically significant objective benefits in patients with chronic primary insomnia [2:2][3:1].
- Glycemic and Insulin Regulation: Daily intake improves glycemic profiles in metabolic disease. Meta-analyses show modest but statistically significant drops in fasting blood glucose and glycosylated hemoglobin (HbA1c) alongside marked increases in total antioxidant capacity [4:1][5:1].
- Mucositis Prevention in Cancer Therapy: Used as an oral rinse, chamomile significantly decreases the severity of oral mucositis and associated throat pain in patients undergoing radiochemotherapy [8][9].
- Systemic Inflammation and Musculoskeletal Pain Relief: Suppresses systemic inflammatory cytokines (CRP, IL-6, TNF-α) and exerts clinically meaningful pain-relieving effects in joint and musculoskeletal disorders like osteoarthritis [10][11].
¶ Evidence summary table (human outcomes)
| Outcome / Goal | Effect* | Consistency** | Evidence quality | Trials*** | Notes (population, duration, dose) |
|---|---|---|---|---|---|
| Generalized Anxiety Disorder (GAD) | High | Moderate | 12 RCTs | Significant HAM-A score reductions; 220–1,500 mg/day of standardized extract for 8–26 weeks [1:2][2:3]. | |
| Subjective Sleep Quality | High | Moderate | 10 RCTs | Significant improvements in sleep quality and latency in elderly, postpartum, and cancer groups [2:4][3:2][9:1]. | |
| Chronic Primary Insomnia | High | Low | 3 RCTs | Negligible objective changes in total sleep time, sleep efficiency, or wake after sleep onset vs. placebo [2:5]. | |
| Glycemic Control (Type 2 Diabetes) | Moderate | Moderate | 10 RCTs | Modest but significant reductions in fasting blood glucose, HbA1c, insulin, and LDL cholesterol [4:2][5:2]. | |
| Systemic Inflammation | High | Moderate | 8 RCTs | Downregulation of circulating inflammatory biomarkers (CRP, IL-6, TNF-α) in diabetic cohorts [10:1]. | |
| Musculoskeletal Pain (Osteoarthritis) | Moderate | Low-to-Moderate | 6 RCTs | Topical chamomile oil or oral extract significantly reduces pain scores and joint stiffness [11:1]. | |
| Chemoradiotherapy Oral Mucositis | High | Moderate | 8 RCTs | Topical chamomile mouthwash reduces the severity and duration of painful oral mucosal lesions [8:1][9:2][12]. | |
| Polycystic Ovary Syndrome (PCOS) | Moderate | Low | 4 RCTs | Improves LH/FSH ratio, reduces total testosterone, and mildly ameliorates insulin resistance [13]. |
- *Effect: Number of arrows (1-3) indicates magnitude. Direction: ↑ (increase), ↓ (decrease), = (no effect), ? (unclear). Health impact: (p) = positive for health, (n) = negative for health, (x) = neutral/unknown impact. Examples: ↓↓↓ (p) = large decrease, positive; ↑ (n) = small increase, negative; = (x) = no effect; ? = unclear.
- *Compact renderer encoding (preferred when using custom tags):
<effect e="[dir][mag][impact]"></effect>wheredir=u|d|e|q,mag=0|1|2|3,impact=p|n|x. Examples:↓↓ (p)-><effect e="d2p"></effect>,= (x)-><effect e="e0x"></effect>,?-><effect e="q0x"></effect>. - IMPORTANT: If using the compact renderer encoding (<effect ...>), do NOT include the text arrows or parentheses next to it. Just use the tag.
- **Consistency: Low (results conflict), Moderate (mixed but leaning one way), High (most trials agree)
- ***Trials: Number of RCTs or total trials informing this outcome (shows evidence depth at a glance)
- REQUIRED: You MUST include a citation key (e.g.
[^1]) in the "Notes" column for every single row. If you claim a result, you must link the specific Meta-Analysis or Key RCT that proves it.
¶ How does Chamomile work?
Chamomile contains over 120 secondary metabolites, including 28 terpenoids and 36 flavonoids. The primary molecular mechanisms include:
- Primary targets: GABA-A receptors (specifically the benzodiazepine binding site), cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, alpha-glucosidase, and inflammatory cytokine pathways (NF-κB, TNF-α, IL-6) [10:2][6:3][12:1].
- Core mechanisms:
- GABA-A Receptor Modulation: The flavone apigenin selectively binds to central benzodiazepine receptors, acting as a competitive partial agonist. This modulates GABAergic neurotransmission, producing mild anxiolytic and sedative effects without causing the muscle relaxation, coordination loss, or physiological dependence typical of full benzodiazepine agonists [2:6][6:4].
- Anti-Inflammatory & Antispasmodic Pathways: Alpha-bisabolol and chamazulene (formed from matricin during steam distillation) inhibit COX-2 and 5-LOX, reducing inflammatory prostaglandin and leukotriene synthesis. Additionally, chamomile components block calcium-induced smooth muscle contractions, relaxing the gastrointestinal tract and suppressing musculoskeletal spasms [10:3][11:2][6:5].
- Glycemic & Antioxidant Mechanisms: Chamomile inhibits intestinal alpha-glucosidase and pancreatic amylase, delaying carbohydrate absorption. Its polyphenols scavenge reactive oxygen species (ROS) and preserve pancreatic beta-cell integrity against oxidative stress, optimizing insulin secretion [4:3][5:3][12:2].
- Pharmacokinetics basics:
- Absorption & Bioavailability: Free apigenin is rapidly absorbed in the upper gastrointestinal tract but undergoes extensive first-pass metabolism (glucuronidation and sulfation). Consequently, free apigenin bioavailability is low (~1.5–2.5%). Standardized extracts are formulated to deliver high concentrations of apigenin glycosides (such as apigenin-7-glucoside), which are hydrolyzed by gut microbiota into the active aglycone, extending absorption kinetics [6:6].
- Half-life & Clearance: The elimination half-life of apigenin in human circulation is roughly 1.5 to 2 hours, with systemic clearance occurring rapidly via biliary and renal excretion. This rapid clearance necessitates divided daily dosing (e.g., twice or thrice daily) to maintain stable therapeutic plasma levels [6:7].
¶ Effects on different systems
¶ Brain & mental health (cognition, mood, sleep)
Chamomile is highly clinically validated for modulating brain neurotransmission to manage mild-to-moderate state and generalized anxiety [1:3][2:7]. Standardized extracts (e.g., 220–1,500 mg daily) significantly decrease anxiety scores and maintain long-term remission [1:4][2:8]. For sleep, chamomile functions as a mild bedtime relaxant, significantly improving subjective sleep quality and sleep onset latency in elderly and postpartum cohorts [2:9][3:3]. However, clinical trials show no significant impact on objective sleep architecture or sleep efficiency in individuals diagnosed with chronic primary insomnia [2:10].
¶ Gut & digestion
In gastrointestinal tissues, chamomile exerts potent spasmolytic, anti-inflammatory, and mucosal protective effects. Its active components (bisabolol and apigenin) reduce smooth muscle spasms, easing cramping, functional dyspepsia, and symptoms of Irritable Bowel Syndrome (IBS) [9:3][6:8]. Furthermore, systematic reviews confirm that topical chamomile oral rinses function as highly effective therapies for oral mucosal lesions, reducing the severity, pain, and duration of radiotherapy- and chemotherapy-induced oral mucositis [8:2][9:4][12:3].
¶ Metabolic health (glycemic markers, insulin, PCOS)
Regular chamomile consumption significantly enhances glycemic profiles and insulin sensitivity in metabolic disorders. Systematic reviews of clinical trials reveal that chamomile intake lowers fasting blood glucose, decreases glycosylated hemoglobin (HbA1c), and improves lipid parameters (reducing LDL and total cholesterol) in individuals with type 2 diabetes [4:4][5:4]. Furthermore, emerging clinical meta-analyses indicate chamomile improves hormonal status in Polycystic Ovary Syndrome (PCOS), showing a significant decrease in serum total testosterone and improvements in the LH/FSH ratio [13:1].
¶ Other domains (musculoskeletal pain & joint health)
In musculoskeletal systems, chamomile’s dual anti-inflammatory and analgesic activities provide measurable relief. In patients with knee osteoarthritis and chronic joint disorders, clinical trials demonstrate that topical chamomile oil application or oral extract supplementation significantly reduces joint pain scores and improves overall physical mobility, driven by the downregulation of systemic inflammatory markers like CRP and TNF-alpha [10:4][11:3].
¶ Dosage and how to take it
¶ Standard dosing in studies
- Generalized Anxiety Disorder (GAD): Standardized oral extracts are administered at 220 mg to 1,500 mg daily, divided into 2–3 equal doses [1:5][2:11].
- Sleep Quality Support: 400 mg to 800 mg extract daily, or 1–2 cups of strong chamomile infusion 45 minutes before bedtime [2:12][3:4].
- Glycemic Control: 3 grams of chamomile flower infusion (as tea) three times daily, consumed immediately after meals [4:5][5:5].
- Oral Mucositis: Swishing and spitting a 1% chamomile solution or a strong chamomile infusion 3–4 times daily [8:3][9:5].
¶ Forms and bioavailability
Dry capsule extracts standardized to 1.2% apigenin are preferred for chronic systemic interventions (such as anxiety and metabolic support) to ensure predictable dosage. Liquid extracts, tinctures, and traditional infusions are highly suited for local gastrointestinal and topical oral contact. Since apigenin is lipophilic, consuming oral extracts alongside dietary fats may enhance intestinal absorption.
¶ Special populations
- Renal or Hepatic Impairment: No dedicated pharmacokinetic trials exist. Because chamomile flavonoids undergo hepatic clearance, individuals with compromised liver function should utilize lower-range dosing.
- Older Adults: Standardized chamomile extracts have been extensively studied in elderly cohorts, demonstrating excellent tolerability and significant improvements in sleep quality [3:5].
- Pregnancy & Breastfeeding: Regular consumption, particularly of Roman chamomile, is not recommended during pregnancy due to a theoretical risk of uterine stimulation and lack of rigorous safety data.
¶ Safety and side effects
¶ Safety Traffic Light
🔴 STOP (Contraindications)
- Asteraceae/Compositae Allergy: Severe allergic reactions (including contact dermatitis and rare anaphylaxis) can occur in individuals with known hypersensitivity to Asteraceae family plants (ragweed, marigolds, daisies, chrysanthemums) [7:1].
- Pregnancy: Regular use of highly concentrated extracts is not recommended due to theoretical uterine stimulation and pelvic blood flow enhancement.
🟡 YIELD (Cautions & Interactions)
- Blood Thinners: Chamomile contains natural coumarins. High doses may have additive effects and increase bleeding risks when combined with anticoagulants or antiplatelet drugs (warfarin, aspirin, clopidogrel) [7:2].
- Central Nervous System Sedatives: May synergize with alcohol, benzodiazepines, barbiturates, or sedating antihistamines, increasing somnolence.
- Antidiabetic Therapy: Due to its blood-sugar-lowering properties, blood glucose should be monitored to prevent hypoglycemia when starting chamomile [4:6].
🟢 GO (Generally Safe For)
¶ Common side effects
Chamomile is widely regarded as a safe botanical agent. When adverse events occur, they are typically mild and transient, including mild nausea, abdominal cramping, or transient dizziness at extremely high doses [7:4].
¶ Less common / serious concerns
The primary clinical risk associated with chamomile is allergic hypersensitivity. Cross-reactivity in individuals allergic to Asteraceae family plants is the most common cause of contact dermatitis, allergic conjunctivitis, and rare systemic hypersensitivity reactions [7:5].
¶ Drug and supplement interactions
¶ Pharmacokinetic interactions (how drugs are processed)
In vitro studies demonstrate that chamomile extracts can inhibit certain Cytochrome P450 (CYP) enzymes, particularly CYP1A2, CYP2C9, CYP2D6, and CYP3A4. Although clinical trials show minimal systemic impacts at typical dietary doses, high-dose chamomile extract use may theoretically increase the plasma concentration of drugs cleared by these pathways (e.g., statins, calcium channel blockers, and certain immunosuppressants) [7:6].
¶ Pharmacodynamic interactions (additive / opposing effects)
- Anticoagulants and Antiplatelets: Natural coumarin derivatives (herniarin and umbelliferone) in chamomile may exert mild antiplatelet effects. Combining high-dose extracts with anticoagulant drugs (e.g., warfarin, apixaban) or antiplatelet medications (e.g., aspirin) may synergistically increase bleeding and bruising risks [7:7].
- Antidiabetic Medications: Because chamomile enhances insulin sensitivity and lowers fasting blood glucose, its co-administration with insulin, metformin, or sulfonylureas may cause additive glucose-lowering effects, requiring careful dosage adjustment [4:7][5:6].
- GABAergic Sedatives: Concomitant use with central nervous system depressants (such as benzodiazepines, zolpidem, or alcohol) may cause additive sedative effects and daytime drowsiness.
¶ Combining Chamomile with other supplements (“stacks”)
- Anxiolytic Daytime Focus Stack: Chamomile extract (220–500 mg) + L-Theanine (100–200 mg). This stack utilizes chamomile's mild GABA-A receptor modulation alongside L-Theanine's ability to promote alpha brain wave activity. The combination reduces state anxiety and improves cognitive focus without causing drowsiness.
- Deep Sleep Foundation Stack: Chamomile extract (400–800 mg) + Valerian Root (300–600 mg) or Passionflower. Valerian root inhibits GABA transaminase (preventing GABA breakdown), while chamomile acts as a GABA-A receptor agonist. This dual pathway provides a gentle, additive sedative action suitable for night-time use.
- Spasmolytic Digestive Stack: Chamomile tea + Peppermint oil. This combination coordinates chamomile’s anti-inflammatory COX-2 inhibition with peppermint’s smooth muscle calcium-channel blocking properties, providing rapid relief for gastrointestinal cramping and functional dyspepsia [9:6].
¶ Practical questions (FAQ)
How long does it take for Chamomile to work?
For acute relaxation, sleep prep, or digestive soothing, chamomile tea or extract typically exerts effects within 30 to 45 minutes of ingestion. For clinical outcomes like generalized anxiety management or glycemic control, benefits are cumulative, requiring consistent daily intake for 2 to 8 weeks [1:6][2:14][4:8].
Can I take Chamomile long-term?
Is Chamomile tea as effective as a standardized extract capsule?
It depends on the clinical objective. For mild sleep prep or local digestive relief, a strong, covered-steeped cup of chamomile tea is highly effective. However, for chronic GAD, standardized extract capsules are preferred to deliver the high, reliable therapeutic doses of apigenin (up to 1,500 mg extract/day) used in clinical trials [1:7][2:16].
Can I use Chamomile if I have seasonal allergies?
It depends on the allergen. If you have a known allergy to plants in the Asteraceae/Compositae family (such as ragweed, marigolds, daisies, or chrysanthemums), you should avoid chamomile or exercise extreme caution, as cross-reactivity can trigger contact dermatitis, allergic rhinitis, or systemic allergic reactions [7:9].
Does Chamomile interact with blood pressure or heart medications?
Chamomile does not directly interact with blood pressure medications, but because high-dose extract may inhibit CYP3A4 and contains natural coumarins, it can theoretically increase the blood levels of certain calcium channel blockers or amplify the effects of blood thinners. Always coordinate high-dose extract protocols with a clinician if you are taking prescription anticoagulants [7:10].
¶ How we evaluated the evidence
This clinical monograph was prepared by systematically prioritizing human clinical evidence, focusing strictly on high-level systematic reviews and meta-analyses of randomized controlled trials (Tier 1), supported by phytochemical and pharmacological characterizations (Tier 2), and clinical toxicological databases (Tier 3).
Evidence quality was graded using the standard GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) framework. High-certainty ratings require multiple, well-powered RCTs with consistent results and low risk of bias. Moderate-certainty represents trials with minor methodological limitations or moderate sample sizes. Low-certainty indicates sparse clinical trials, inconsistent results, or reliance on indirect surrogates, while Very Low-certainty refers to evidence based solely on animal, in vitro, or observational studies.
¶ References
Saadatmand S, Zohroudi F, Tangestani H. The Effect of Oral Chamomile on Anxiety: A Systematic Review of Clinical Trials. Clinical Nutrition Research. 2024. https://pubmed.ncbi.nlm.nih.gov/38784853/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Hieu TH, Dibas M, Surya Dila KA, et al. Therapeutic efficacy and safety of chamomile for state anxiety, generalized anxiety disorder, insomnia, and sleep quality: A systematic review and meta-analysis of randomized trials and quasi-randomized trials. Phytotherapy Research. 2019. https://pubmed.ncbi.nlm.nih.gov/31006899/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Kazemi A, Shojaei-Zarghani S, Eskandarzadeh P. Effects of chamomile (Matricaria chamomilla L.) on sleep: A systematic review and meta-analysis of clinical trials. Complementary Therapies in Medicine. 2024. https://pubmed.ncbi.nlm.nih.gov/39106912/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Akhgarjand C, Moludi J, Ebrahimi-Mousavi S. The effect of chamomile consumption on glycemic markers in humans and animals: a systematic review and meta-analysis. Journal of Diabetes and Metabolic Disorders. 2024. https://pubmed.ncbi.nlm.nih.gov/38932814/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Hajizadeh-Sharafabad F, Varshosaz P, Jafari-Vayghan H. Chamomile (Matricaria recutita L.) and diabetes mellitus, current knowledge and the way forward: A systematic review. Complementary Therapies in Medicine. 2020. https://pubmed.ncbi.nlm.nih.gov/31987240/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
El Mihyaoui A, Esteves da Silva JCG, Charfi S. Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. Life (Basel). 2022. https://pubmed.ncbi.nlm.nih.gov/35454969/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Ostovar M, Rezaee Z, Najibi SM. Chamomile: A systematic review of adverse events. Complementary Therapies in Medicine. 2025. https://pubmed.ncbi.nlm.nih.gov/40374153/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
de Lima Dantas JB, Freire TFC, Sanches ACB. Action of Matricaria recutita (chamomile) in the management of radiochemotherapy oral mucositis: A systematic review. Phytotherapy Research. 2022. https://pubmed.ncbi.nlm.nih.gov/35129844/ ↩︎ ↩︎ ↩︎ ↩︎
Maleki M, Mardani A, Manouchehri M. Effect of Chamomile on the Complications of Cancer: A Systematic Review. Integrative Cancer Therapies. 2023. https://pubmed.ncbi.nlm.nih.gov/37052390/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Valmy J, Greenfield S, Shindo S. Anti-inflammatory effect of chamomile from randomized clinical trials: a systematic review and meta-analyses. Pharmaceutical Biology. 2025. https://pubmed.ncbi.nlm.nih.gov/40665590/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Ahmadi M, Mozaffarpur SA, Shirafkan H. Effect of chamomile on musculoskeletal pain: A systematic review and meta-analysis of randomized controlled trials. Caspian Journal of Internal Medicine. 2025. https://pubmed.ncbi.nlm.nih.gov/41394268/ ↩︎ ↩︎ ↩︎ ↩︎
Salehi B, Lopez-Jornet P, Pons-Fuster López E, et al. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties. Biomolecules. 2019. https://pubmed.ncbi.nlm.nih.gov/30884918/ ↩︎ ↩︎ ↩︎ ↩︎
Firoozi Z, Molani-Gol R, Ebrahimzadeh-Attari V. Evaluating Potential Effects of Chamomile (Matricaria chamomilla L.) in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Food Science & Nutrition. 2026. https://pubmed.ncbi.nlm.nih.gov/41767834/ ↩︎ ↩︎